In that study, they identified antigen presentation, interferon (IFN) activity and B cell activity to be enriched in good responders to preoperative CRT in locally advanced rectal cancer (LARC) patients, and that these factors may relate to good responses to the treatment via activation of an antiviral-like response and CD8+ T cell recruitment. The gene discussed is IFNA1; the disease is rectal cancer.